Bolt Biotherapeutics BOLT
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 4.04 | -4.31 | -7,601 | -7 | ||
| 2025Q4 | 5.47 | 106.85 | -3.91 | -7,085 | -7 | |
| 2025Q3 | 5.32 | 107.82 | -3.72 | -7,703 | -7 | |
| 2025Q2 | 5.77 | 107.58 | -4.42 | -9,210 | -9 | |
| 2025Q1 | 8 | 109.74 | -5.8 | -12,115 | -11 | |
| 2024Q4 | 10.7 | 106.15 | -8.33 | -16,916 | -16 | |
| 2024Q3 | 12.96 | 108.35 | -7.93 | -16,443 | -15 | |
| 2024Q2 | 15 | 106.61 | -11.2 | -22,597 | -21 | |
| 2024Q1 | 28 | 158.1 | -5.6 | -17,092 | -11 | |
| 2023Q4 | 22.4 | 110.41 | -9.4 | -19,766 | -18 | |
| 2023Q3 | 20.8 | 111.85 | -8.6 | -18,183 | -16 | |
| 2023Q2 | 25.6 | 109.83 | -9.6 | -19,832 | -18 | |
| 2023Q1 | 27.8 | 108.45 | -9 | -18,415 | -17 | |
| 2022Q4 | 26 | 105.22 | -10.6 | -21,040 | -20 | |
| 2022Q3 | 29.6 | 102.7 | -11.6 | -22,346 | -22 | |
| 2022Q2 | 40.8 | 101.74 | -12.2 | -23,059 | -23 | |
| 2022Q1 | 54.8 | 100.84 | -12.8 | -23,876 | -24 | |
| 2021Q4 | 98 | 99.7 | -14.6 | -27,075 | -27 | |
| 2021Q3 | 253 | 100.56 | -11.8 | -23,526 | -23 | |
| 2021Q2 | 309.2 | 100.75 | -10.2 | -23,761 | -24 |